Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する実験動画

遅れた思春期の成功治療中にメラトニン産生が急速に減少する.

J Arendt, M H Labib, C Bojkowski

    Lancet (London, England)
    |June 10, 1989
    PubMed
    まとめ

    No abstract available in PubMed .

    関連する実験動画

    関連する概念動画

    こちらも読む

    関連記事

    共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

    並び替え
    Same author

    Effectiveness and feasibility of a theory-informed intervention to improve Mediterranean diet adherence, physical activity and cognition in older adults at risk of dementia: the MedEx-UK randomised controlled trial.

    BMC medicine·2024
    Same author

    Facilitating the transition from hospital to home after hip fracture surgery: a qualitative study from the HIP HELPER trial.

    BMC geriatrics·2024
    Same author

    'This is silent murder' - are we medicalising human distress caused by the reality of life as an asylum seeker in the UK?

    Perspectives in public health·2024
    Same author

    Avelumab first-line maintenance treatment for advanced urothelial carcinoma: review of evidence to guide clinical practice.

    ESMO open·2023
    Same author

    We care but we're not carers: perceptions and experiences of social prescribing in a UK national community organisation.

    Perspectives in public health·2023
    Same author

    Lest we forget. Illuminating lived experience of the Covid-19 pandemic and lockdown.

    Social science & medicine (1982)·2023
    Same journal

    Assisted dying and the silencing of medicine's next generation.

    Lancet (London, England)·2026
    Same journal

    Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

    Lancet (London, England)·2026
    Same journal

    Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

    Lancet (London, England)·2026
    Same journal

    [<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

    Lancet (London, England)·2026
    Same journal

    Research priorities for characterising Bundibugyo virus.

    Lancet (London, England)·2026
    Same journal

    Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

    Lancet (London, England)·2026
    関連記事をすべて見る